Regulating the p53 pathway: in vitro hypotheses, in vivo veritas - PubMed (original) (raw)

Review

doi: 10.1038/nrc2012.

Affiliations

• PMID: 17128209
• DOI: 10.1038/nrc2012

Review

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Franck Toledo et al. Nat Rev Cancer. 2006 Dec.

Abstract

Mutations in TP53, the gene that encodes the tumour suppressor p53, are found in 50% of human cancers, and increased levels of its negative regulators MDM2 and MDM4 (also known as MDMX) downregulate p53 function in many of the rest. Understanding p53 regulation remains a crucial goal to design broadly applicable anticancer strategies based on this pathway. This Review of in vitro studies, human tumour data and recent mouse models shows that p53 post-translational modifications have modulatory roles, and MDM2 and MDM4 have more profound roles for regulating p53. Importantly, MDM4 emerges as an independent target for drug development, as its inactivation is crucial for full p53 activation.

PubMed Disclaimer

References

1. 1. Nature. 1995 Nov 9;378(6553):206-8 - PubMed
2. 1. Cell Death Differ. 2006 Jun;13(6):951-61 - PubMed
3. 1. Genes Chromosomes Cancer. 2002 Feb;33(2):133-40 - PubMed
4. 1. Mol Cell Biol. 2000 Dec;20(24):9391-8 - PubMed
5. 1. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal